Evidence map›Paper›PMID 25954607›Full record

ArticleFrontiers in oncology2015

Clinical Significance of NOTCH1 and NOTCH2 Expression in Gastric Carcinomas: An Immunohistochemical Study.

Lukas Bauer, Agnes Takacs, Julia Slotta-Huspenina, Rupert Langer, Karen Becker, Alexander Novotny, Katja Ott, Axel Walch, Alexander Hapfelmeier, Gisela Keller

Open access · goldAbstract read
In one paragraph

Article in Frontiers in oncology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Elevated Expression of NOTCH1 Associates with Lymph Node Metastasis of Gastric Cancer and Knock-Down of NOTCH1 Attenuates Tumor Cell Progression.Medical science monitor : international medical journal of experimental and clinical research · 2019
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Notch as a Driver of Gastric Epithelial Cell Proliferation.Cellular and molecular gastroenterology and hepatology · 2017
    Review
  15. Article
  16. NOTCH1 and NOTCH2 regulate epithelial cell proliferation in mouse and human gastric corpus.American journal of physiology. Gastrointestinal and liver physiology · 2017
    Article
  17. Notch regulation of gastrointestinal stem cells.The Journal of physiology · 2016
    Review
  18. Article
  19. Article
  20. Tumor Suppressor Role of miR-363-3p in Gastric Cancer.Medical science monitor : international medical journal of experimental and clinical research · 2015
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Lukas BauerInstitute of Pathology, Technische Universität München , Munich , Germany.
Agnes TakacsInstitute of Pathology, Technische Universität München , Munich , Germany.
Julia Slotta-HuspeninaInstitute of Pathology, Technische Universität München , Munich , Germany.
Rupert LangerDepartment of Pathology, University of Bern , Bern , Switzerland.
Karen BeckerInstitute of Pathology, Technische Universität München , Munich , Germany.
Alexander NovotnyDepartment of Surgery, Technische Universität München , Munich , Germany.
Katja OttDepartment of Surgery, Klinikum Rosenheim , Rosenheim , Germany.
Axel WalchInstitute of Pathology, Helmholtz-Zentrum München , Neuherberg , Germany.
Alexander HapfelmeierInstitute of Medical Statistics and Epidemiology, Technische Universität München , Munich , Germany.
Gisela KellerInstitute of Pathology, Technische Universität München , Munich , Germany.
Technical University of Munich · DEHelmholtz Zentrum München · DERosenheim Technical University of Applied Sciences · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundNOTCH signaling can exert oncogenic or tumor suppressive functions and can contribute to chemotherapy resistance in cancer. In this study, we aimed to clarify the clinicopathological significance and the prognostic and predictive value of NOTCH1 and NOTCH2 expression in gastric cancer (GC).

methodsNOTCH1 and NOTCH2 expression was determined immunohistochemically in 142 primarily resected GCs using tissue microarrays and in 84 pretherapeutic biopsies from patients treated by neoadjuvant chemotherapy. The results were correlated with survival, response to therapy, and clinico-pathological features.

resultsPrimarily resected patients with NOTCH1-negative tumors demonstrated worse survival. High NOTCH1 expression was associated with early-stage tumors and with significantly increased survival in this subgroup. Higher NOTCH2 expression was associated with early-stage and intestinal-type tumors and with better survival in the subgroup of intestinal-type tumors. In pretherapeutic biopsies, higher NOTCH1 and NOTCH2 expression was more frequent in non-responding patients, but these differences were statistically not significant.

conclusionOur findings suggested that, in particular, NOTCH1 expression indicated good prognosis in GC. The close relationship of high NOTCH1 and NOTCH2 expression with early tumor stages may indicate a tumor-suppressive role of NOTCH signaling in GC. The role of NOTCH1 and NOTCH2 in neoadjuvantly treated GC is limited.

Indexed as

chemotherapyimmunohistochemistryprognosisreceptor NOTCH1receptor NOTCH2stomach neoplasms

Identifiers

PMID25954607
PMCPMC4406075
OpenAlexW2023902925

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.